These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 9632590

  • 21. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM, Hammer J, Sinigaglia F, Clavijo P, Moya-Castro ZR, Nardin EH.
    J Immunol; 1997 Aug 01; 159(3):1362-73. PubMed ID: 9233633
    [Abstract] [Full Text] [Related]

  • 22. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM, Burns JM.
    J Immunol; 2008 Jan 01; 180(1):444-53. PubMed ID: 18097046
    [Abstract] [Full Text] [Related]

  • 23. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between Plasmodium vivax PvDBP and Plasmodium falciparum VAR2CSA.
    Mitran CJ, Mena A, Gnidehou S, Banman S, Arango E, Lima BAS, Lugo H, Ganesan A, Salanti A, Mbonye AK, Ntumngia F, Barakat K, Adams JH, Kano FS, Carvalho LH, Maestre AE, Good MF, Yanow SK.
    mBio; 2019 Oct 08; 10(5):. PubMed ID: 31594821
    [Abstract] [Full Text] [Related]

  • 24. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R, Wunderlich G, Ferreira MU.
    J Eukaryot Microbiol; 2001 Oct 08; 48(5):556-64. PubMed ID: 11596920
    [Abstract] [Full Text] [Related]

  • 25. Recombinant chimeric proteins generated from conserved regions of Plasmodium falciparum merozoite surface protein 2 generate antiparasite humoral responses in mice.
    Lawrence N, Stowers A, Mann V, Taylor D, Saul A.
    Parasite Immunol; 2000 May 08; 22(5):211-21. PubMed ID: 10792760
    [Abstract] [Full Text] [Related]

  • 26. Predominance of H-2d- and H-2k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332.
    Ahlborg N, Sterky F, Haddad D, Perlmann P, Nygren PA, Andersson R, Berzins K.
    Mol Immunol; 1997 Apr 08; 34(5):379-89. PubMed ID: 9293771
    [Abstract] [Full Text] [Related]

  • 27. Characterization of fine specificity of the immune response to a Plasmodium falciparum rhoptry neck protein, PfAARP.
    Kalra A, Mukherjee P, Chauhan VS.
    Malar J; 2016 Sep 07; 15(1):457. PubMed ID: 27604988
    [Abstract] [Full Text] [Related]

  • 28. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C, Troye-Blomberg M, Deloron P, Kabilan L, Lepers JP, Savel J, Perlmann P.
    J Immunol; 1991 Oct 01; 147(7):2295-301. PubMed ID: 1717554
    [Abstract] [Full Text] [Related]

  • 29. Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.
    Ray P, Sahoo N, Singh B, Kironde FA.
    Infect Immun; 1994 Jun 01; 62(6):2354-61. PubMed ID: 8188358
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the immunogenicity and vaccine potential of recombinant Plasmodium falciparum merozoite surface protein 8.
    Alaro JR, Angov E, Lopez AM, Zhou H, Long CA, Burns JM.
    Infect Immun; 2012 Jul 01; 80(7):2473-84. PubMed ID: 22585960
    [Abstract] [Full Text] [Related]

  • 31. Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology.
    Okitsu SL, Mueller MS, Amacker M, Vogel D, Westerfeld N, Robinson JA, Zurbriggen R, Pluschke G.
    Hum Vaccin; 2008 Jul 01; 4(2):106-14. PubMed ID: 18382133
    [Abstract] [Full Text] [Related]

  • 32. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP, Perlaza BL, Brahimi K, Daubersies P, Druilhe P.
    Infect Immun; 2001 Feb 01; 69(2):1202-6. PubMed ID: 11160023
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME, Golden HE, Doll TA, Yang Y, Kaba SA, Zou X, Gerbasi VR, Burkhard P, Lanar DE.
    Malar J; 2013 Apr 22; 12():136. PubMed ID: 23607541
    [Abstract] [Full Text] [Related]

  • 34. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED, Corradin G, Hoffman SL.
    J Immunol; 1997 Oct 01; 159(7):3424-33. PubMed ID: 9317141
    [Abstract] [Full Text] [Related]

  • 35. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion.
    Sim BK, Orlandi PA, Haynes JD, Klotz FW, Carter JM, Camus D, Zegans ME, Chulay JD.
    J Cell Biol; 1990 Nov 01; 111(5 Pt 1):1877-84. PubMed ID: 2229177
    [Abstract] [Full Text] [Related]

  • 36. Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection.
    Gibbins MP, Müller K, Glover M, Liu J, Putrianti ED, Bauza K, Reyes-Sandoval A, Matuschewski K, Silvie O, Hafalla JCR.
    Infect Immun; 2020 Sep 18; 88(10):. PubMed ID: 32719159
    [Abstract] [Full Text] [Related]

  • 37. Potentiation of immune response against the RESA peptides of Plasmodium falciparum by incorporating a universal T-cell epitope (CS.T3) and an immunomodulator (polytuftsin), and delivery through liposomes.
    Kumar P, Biswas S, Rao DN.
    Microbiol Immunol; 1999 Sep 18; 43(6):567-76. PubMed ID: 10480553
    [Abstract] [Full Text] [Related]

  • 38. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM, Oliveira GA, Watta CO, Soverow J, Parra-Lopez C, Nardin EH.
    Infect Immun; 2006 Dec 18; 74(12):6929-39. PubMed ID: 17030584
    [Abstract] [Full Text] [Related]

  • 39. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D, Michel M, Müller I, Tougne C, Rènia L, Mazier D, Corradin G, Lambert PH, Louis JA, Del Guidice G.
    Eur J Immunol; 1990 Jun 18; 20(6):1215-22. PubMed ID: 1695152
    [Abstract] [Full Text] [Related]

  • 40. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R, DeBot M, Porter M, Nikki J, Rein L, Spaccapelo R, Crisanti A, Wightman PD, Ockenhouse CF, Dutta S.
    PLoS One; 2014 Jun 18; 9(10):e111020. PubMed ID: 25343487
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.